Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?

Authors : Lahtela Heli H; Karjalainen Pasi P PP; Niemelä Matti M; Vikman Saila S; Kervinen Kari K; Ylitalo Antti A; Puurunen Marja M; Porela Pekka P; Nyman Kai K; Hinkka-Yli-Salomäki Susanna S; Airaksinen K E Juhani KE;

Affiliations : Department of Medicine, Turku University Hospital, Turku, Finland.

Journal : Thromb. Haemost.   (2009)

Related Links: Pubmed | Publisher website

Another oral thrombin inhibitor for stroke preventionin atrial fibrillation?

Authors : Eikelboom John W JW; Weitz Jeffrey I JI;

Affiliations : N/A

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Authors : Olsson S Bertil SB; Rasmussen Lars H LH; Tveit Arnljot A; Jensen Eva E; Wessman Peter P; Panfilov Seva S; Wåhlander Karin K;

Affiliations : Department of Cardiology, Lund University Hospital, Lund, Sweden. Bertil.Olsson@med.lu.se

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?

Authors : Marín Francisco F; Bonacasa Bárbara B; Valdés Mariano M;

Affiliations : N/A

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.

Authors : Lip Gregory Y H GY; Huber Kurt K; Andreotti Felicita F; Arnesen Harald H; Airaksinen K Juhani KJ; Cuisset Thomas T; Kirchhof Paulus P; Marín Francisco F; ;

Affiliations : University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, United Kingdom. g.y.h.lip@bham.ac.uk

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

New oral anticoagulants in development.

Authors : Weitz Jeffrey I JI;

Affiliations : Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada. jweitz@thrombosis.hhscr.org

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?

Authors : Lane D A DA; Lip G Y H GY;

Affiliations : N/A

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.

Authors : Pengo V V; Cucchini U U; Denas G G; Davidson B L BL; Marzot F F; Jose S P SP; Iliceto S S;

Affiliations : Clinical Cardiology, Thrombosis Center, University of Padova School of Medicine, Via Giustiniani 2, 35128 Padova, Italy. vittorio.pengo@unipd.it

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Anticoagulation for valvular heart disease in community-basedpractice.

Authors : Rose A J AJ; Ozonoff A A; Henault L E LE; Hylek E M EM;

Affiliations : Center for Health Quality, Outcomes, and Economic Research, Bedford VA Medical Center, 200 Springs Road, Building 70, Bedford, MA 01730, USA. adamrose@bu.edu

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website